US Patent Issued to Astellas Pharma, Medivation Prostate Therapeutics on Dec. 23 for "Formulations of enzalutamide" (American, Japanese Inventors)

ALEXANDRIA, Va., Dec. 23 -- United States Patent no. 12,502,357, issued on Dec. 23, was assigned to Astellas Pharma Inc. (Tokyo) and Medivation Prostate Therapeutics LLC (New York).

"Formulations of enzalutamide" was invented by Douglas Alan Lorenz (Bend, Ore.), Sanjay Konagurthu (Bend, Ore.), Randy J. Wald (Bend, Ore.), Jason A. Everett (Bend, Ore.), Sheila Matz (North Conway, N.H.), Yuuki Takaishi (Tokyo), Toshiro Sakai (Tokyo), Ryousuke Irie (Tokyo), Shinsuke Oba (Tokyo), Hiroyasu Toyota (Tokyo), Koji Nishimura (Tokyo) and Atsushi Kanbayashi (Tokyo).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure provides formulations of enzalutamide and their use for treating hyperproliferative disorders."...